Cleared Traditional

K181310 - HeartCheck Cardi Beat ECG Monitor with GEMS Mobile

K181310 is an FDA 510(k) clearance for HeartCheck Cardi Beat ECG Monitor with ..., manufactured by Cardiocomm Solutions, Inc.. The device is a Class 2 Cardiovascular device with product code DXH cleared through the Traditional 510(k) pathway after a 281-day FDA review.

K181310 · Cardiocomm Solutions, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2019
Decision
281d
Days
Class 2
Risk

K181310 is an FDA 510(k) clearance for the HeartCheck Cardi Beat ECG Monitor with GEMS Mobile. Classified as Transmitters And Receivers, Electrocardiograph, Telephone (product code DXH), Class II - Special Controls.

Submitted by Cardiocomm Solutions, Inc. (North York, CA). The FDA issued a Cleared decision on February 22, 2019 after a review of 281 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2920 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Cardiocomm Solutions, Inc. devices

FDA 510(k) Submission Details - K181310

510(k) Number K181310 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 17, 2018
Decision Date February 22, 2019
Days to Decision 281 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
156d slower than avg
Panel avg: 125d · This submission: 281d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXH Device Classification - Class 2, Special Controls

Product Code DXH Transmitters And Receivers, Electrocardiograph, Telephone
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2920
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXH Transmitters And Receivers, Electrocardiograph, Telephone

All 175
Devices cleared under the same product code (DXH) and FDA review panel - the closest regulatory comparables to K181310.
Study Watch with Irregular Pulse Monitor
K192415 · Verily Life Sciences, LLC · Jan 2020
Triangle System
K183319 · AliveCor, Inc. · May 2019
KardiaMobile, KardiaStation
K182396 · AliveCor, Inc. · Apr 2019
RX-1 Rhythm Express Remote Cardiac Monitoring System
K183704 · Vivaquant, Inc. · Feb 2019
Coala Heart Monitor
K182040 · Coala Life AB · Feb 2019
Study Watch
K182456 · Verily Life Sciences, LLC · Jan 2019